Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in LITS — Lite Strategy, Inc.

CIK 19617 NEW YORK, NY
Back to LITS Full portfolio

Position in LITS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$60
-$17 QoQ
Shares Held
67
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 35 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 61% Shared 0% None 39%

Common Shares in LITS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,192 across 425 Biotechnology names. LITS ranks #403 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in LITS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60 67
2026-03-31 $77 67
2025-12-31 $88 67
2025-09-30 $161 67
2025-06-30 $165 67
2025-03-31 $175 81
2024-12-31 $202 83
2024-09-30 $235 83
2024-06-30 $165 57
2024-03-31 $228 57
2023-12-31 $306 53
2023-09-30 $3,266 466
2023-06-30 $269 41